Boston Scientific Corporation – Filings and Transcripts

NYSE: BSX
Share price (5/5/26): $55.98
Market cap (5/5/26): $83.2 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Business combination disclosure

Prospectus supplement

Details of business combination or exchange offer – amended

Business combination disclosure

Details of business combination or exchange offer

Ownership Filter

O'Connor Padraig Andrew

Butcher Arthur C

Vanguard Capital Management LLC

Vanguard Group Inc

News Filter

Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Shareholder Vote Results, Financial Statements or Exhibits

Announces Results for First Quarter 2026

HI-PEITHO Trial Demonstrates Boston Scientific EKOS™ Endovascular System Is Superior to Standard of Care for Treatment of Acute Pulmonary Embolism

Material Definitive Agreement, Termination of Material Definitive Agreement, New Financial Obligation or Off-Balance Sheet Arrangement, Financial Statements or Exhibits

Elects Cathy Smith and Christophe Weber to Board of Directors

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Scanned paper annual report submission

Letter from the SEC

Conflict Minerals disclosure